H3K56 acetylation affects Candida albicans morphology and secreted soluble factors interacting with the host.

Candida albicans ChIP-seq Farnesol H3K56 acetylation Macrophage response RNA-seq

Journal

Biochimica et biophysica acta. Gene regulatory mechanisms
ISSN: 1876-4320
Titre abrégé: Biochim Biophys Acta Gene Regul Mech
Pays: Netherlands
ID NLM: 101731723

Informations de publication

Date de publication:
15 Jun 2024
Historique:
received: 08 03 2024
revised: 17 05 2024
accepted: 10 06 2024
medline: 18 6 2024
pubmed: 18 6 2024
entrez: 17 6 2024
Statut: aheadofprint

Résumé

In recent years, epigenetics has been revealed as a mechanism able to modulate the expression of virulence traits in diverse pathogens, including Candida albicans. Indeed, epigenetic regulation can sense environmental changes, leading to the rapid and reversible modulation of gene expression with consequent adaptation to novel environments. How epigenetic changes can impact expression and signalling output, including events associated with mechanisms of morphological transition and virulence, is still poorly studied. Here, using nicotinamide as a sirtuin inhibitor, we explored how the accumulation of the H3K56 acetylation, the most prominent histone acetylation in C. albicans, might affect its interaction with the host. Our experiments demonstrate that H3K56 acetylation profoundly affects the production and/or secretion of soluble factors compromising actin remodelling and cytokine production. ChIP- and RNA-seq analyses highlighted a direct impact of H3K56 acetylation on genes related to phenotypic switching, biofilm formation and cell aggregation. Direct and indirect regulation also involves genes related to cell wall protein biosynthesis, β-glucan and mannan exposure, and hydrolytic secreted enzymes, supporting the hypothesis that the fluctuations of H3K56 acetylation in C. albicans might impair the macrophage response to the yeast and thus promote the host-immune escaping.

Identifiants

pubmed: 38885737
pii: S1874-9399(24)00044-0
doi: 10.1016/j.bbagrm.2024.195048
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

195048

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work described in this paper.

Auteurs

Marisa Conte (M)

Department of Pharmacy, University of Salerno, Fisciano (SA), Italy; Ph.D. Program in Drug Discovery and Development, University of Salerno, Fisciano (SA), Italy.

Daniela Eletto (D)

Department of Pharmacy, University of Salerno, Fisciano (SA), Italy.

Martina Pannetta (M)

Department of Pharmacy, University of Salerno, Fisciano (SA), Italy; Ph.D. Program in Drug Discovery and Development, University of Salerno, Fisciano (SA), Italy.

Roberta Esposito (R)

Department of Pharmacy, University of Salerno, Fisciano (SA), Italy.

Maria Chiara Monti (MC)

Department of Pharmacy, University of Salerno, Fisciano (SA), Italy; Department of Pharmacy, University of Naples "Federico II", Italy.

Elva Morretta (E)

Department of Pharmacy, University of Salerno, Fisciano (SA), Italy.

Peter Tessarz (P)

Max Planck Research Group "Chromatin and Ageing", Max Planck Institute for Biology of Ageing, University of Cologne, Germany; Cologne Excellence Cluster on Stress Responses in ageing-associated Diseases (CECAD), University of Cologne, Germany; Dept. Of Human Biology, Radboud Institute for Molecular Life Sciences, Faculty of Science, Radboud University, Nijmegen, the Netherlands.

Silvana Morello (S)

Department of Pharmacy, University of Salerno, Fisciano (SA), Italy.

Alessandra Tosco (A)

Department of Pharmacy, University of Salerno, Fisciano (SA), Italy. Electronic address: tosco@unisa.it.

Amalia Porta (A)

Department of Pharmacy, University of Salerno, Fisciano (SA), Italy. Electronic address: aporta@unisa.it.

Classifications MeSH